SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-010767
Filing Date
2017-05-12
Accepted
2017-05-12 16:16:39
Documents
54
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pti-10q_20170331.htm 10-Q 1221366
2 EX-31.1 pti-ex311_10.htm EX-31.1 12124
3 EX-31.2 pti-ex312_7.htm EX-31.2 12039
4 EX-32.1 pti-ex321_6.htm EX-32.1 13263
  Complete submission text file 0001564590-17-010767.txt   4176538

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pti-20170331.xml EX-101.INS 898460
6 XBRL TAXONOMY EXTENSION SCHEMA pti-20170331.xsd EX-101.SCH 30938
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pti-20170331_cal.xml EX-101.CAL 42717
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pti-20170331_def.xml EX-101.DEF 48141
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pti-20170331_lab.xml EX-101.LAB 219569
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pti-20170331_pre.xml EX-101.PRE 160221
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-37695 | Film No.: 17838836
SIC: 2834 Pharmaceutical Preparations